Clinical Trial

Role of MRI Assessment in Fertility Sparing Treatment for Cervical Cancer at Staging and Follow-up and for Identification of Risk Factors for Aggressive Disease.

Study acronym: FEST-CC
Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to investigate the role of MRI, including DWI, in the staging and evaluation of response to fertility sparing treatment, including both primary surgery Protocol FeST-CC V.1.0 of November 10, 2023 Pag. 5 \| 23 (RT or CKC) or after NACT, followed by CKC, in patients with ECC (FIGO 2018 stage IB1- IIA1), desiring to preserve their fertility.
Trial Details
NCT Number NCT06877065
Lead Sponsor Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions Cervical Cancer
Enrollment 60 participants
Start Date 2024-03-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-03-14